Legal

David Simon, J.D., LL.M., Ph.D., examines the unresolved gray areas between physicians, hospitals and AI manufacturers when errors occur.

Drawing from past device litigation, David Simon, J.D., LL.M., Ph.D., outlines how product liability claims against AI developers and device makers may mirror — and expand upon — traditional malpractice law.

David Simon, J.D., LL.M., Ph.D., discusses how AI could gradually reshape the legal definition of the “standard of care," and what happens when not all physicians or systems have equal access to these tools.

David Simon, J.D., LL.M., Ph.D., explains why the first clues to artificial intelligence malpractice law may come from outside of medicine — including recent verdicts in the autonomous vehicle industry.

Sara Gerke of the University of Illinois explains how artificial intelligence is already challenging malpractice law — and why unclear liability could slow safe adoption.

At the MGMA Leaders Conference 2025, Jason Jobes of Norwood shares a practical blueprint for helping physician practices transition to value-based care.

Jason Jobes of Norwood explains why meaningful physician engagement in value-based care starts with simple conversations, not dashboards or data dumps.

Jason Jobes of Norwood explains how practices can balance revenue maximization with compliance as regulators intensify audits and scrutiny over coding accuracy.

Jason Jobes of Norwood outlines why taking the right amount of financial risk — and investing in infrastructure — is essential for practices transitioning to VBC.

Deepika Srivastava of The Doctors Company breaks down how AI is transforming medical malpractice — from shifting standards of care to new liability risks — and what physicians must do now to stay protected.

Deepika Srivastava of The Doctors Company discusses how AI is transforming medicine — and why physicians must stay engaged as the technology evolves.

Ohio State researchers say the billionaire entrepreneur’s Cost Plus Drug Company exposes how insurance premiums and middlemen drive up the true cost of neurologic medications.

Deepika Srivastava of The Doctors Company explains how malpractice insurers can guide physicians through the legal and clinical challenges of AI.

Deepika Srivastava of The Doctors Company explains how open communication and patient consent can reduce malpractice risk when using AI tools.

Deepika Srivastava of The Doctors Company explains how insurers are beginning to adjust coverage as artificial intelligence tools become more common in medical practice.

Deepika Srivastava of The Doctors Company outlines the most practical steps physicians can take to mitigate legal risk when using AI tools in patient care.

Deepika Srivastava of The Doctors Company explains why the legal system is still catching up to artificial intelligence — and how future court cases could reshape malpractice law.

Deepika Srivastava of The Doctors Company breaks down the unanswered question at the heart of AI-related malpractice: who’s responsible — the physician, the health system or the technology company?

Deepika Srivastava of The Doctors Company explains why the rise of AI in medicine is outpacing the legal system’s ability to manage its risks.

Artificial intelligence is entering exam rooms faster than malpractice law can keep up. Here’s what physicians need to know about how to use these tools without inviting avoidable risk.

Tail coverage isn’t just for retirement: Here’s what every physician should know

As cyberattacks grow more sophisticated, physician practices face mounting risks that can jeopardize patient trust, data security and financial stability.

Navigating the sale of a medical practice involves crucial tax strategies that maximize after-tax proceeds and ensure a successful financial transition.

The key terms and protections physician groups need to know before signing a contract

The Doctors Company warns economic and social inflation are driving higher malpractice costs, fueled by large verdicts and litigation financing.